Gene-silencing to curb LDL-C ‘could dramatically cut CVD risk’

Researchers have attempted to simulate a 50-year randomised controlled trial.
Medicom
Test ordering LDL cholesterol

AusDoc brings you the latest news from the European Society of Cardiology Congress 2021.

Having an annual ‘vaccination’ from the age of 30 to reduce LDL-cholesterol (LDL-C) levels could have a dramatic effect on the risk of major cardiovascular events, UK researchers say.